NCT06749106 Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage
| NCT ID | NCT06749106 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig-Maximilians - University of Munich |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-01-16 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-01-16 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the association between intraplaque hemorrhage (IPH) detected by non-contrast magnetic resonance imaging (MRI) of the carotid artery in routine clinical practice and ipsilateral acute ischemic events. The investigators' overarching aim is to determine whether this sequence aids the diagnostic work-up of stroke patients. For this purpose, the investigators set up a prospective single-center longitudinal observational study with one year follow-up. In addition, this study will analyze retrospectively obtained data collected through clinical routine.
Eligibility Criteria
Inclusion Criteria: * Patients with acute ischemic stroke * Availability of non-contrast carotid MRI scans obtained through routine diagnostic work-up Exclusion Criteria: * Infarct in the posterior circulation or bilateral ischemic infarcts * Time between symptom onset and non-contrast carotid MRI \> 10 days * Prior stenting of a carotid artery or carotid endarterectomy * Age \< 18 years * Life expectancy \< 1 year * Inability to provide written informed consent This eligibility criteria apply for the prospective part of the PARADE study.
Contact & Investigator
Anna Kopczak, MD
PRINCIPAL INVESTIGATOR
Institute for Stroke and Dementia Research
Frequently Asked Questions
Who can join the NCT06749106 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06749106 currently recruiting?
Yes, NCT06749106 is actively recruiting participants. Contact the research team at isd@med.uni-muenchen.de for enrollment information.
Where is the NCT06749106 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT06749106 clinical trial?
NCT06749106 is sponsored by Ludwig-Maximilians - University of Munich. The principal investigator is Anna Kopczak, MD at Institute for Stroke and Dementia Research. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.